Ectopic pregnancy: A 1 in 1.4 × 10<sup>8</sup>patient

Irvine, L. M.; Setchell, M. E.

doi:10.1080/01443610902946895

Cited by 1 publication

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clinical symptoms at initial presentation are variable. The most common clinical manifestation was abdominal pain in 7 cases [ 3 , 13 ], followed by abdominal distension (n = 4) [ 14 – 17 ], and an abdominal palpable mass (n = 3) [ 3 , 5 , 16 ], abdominal bloating (n = 3) [ 3 ], abdominal discomfort (n = 1) [ 2 ], postmenopausal vaginal bleeding (n = 1) [ 3 ], and dysarthria due to brain metastasis (n = 1) [ 8 ]. In our report, abdominal distension, abdominal discomfort, and urinary frequency occurred in one case each.…”

Section: Discussionmentioning

confidence: 99%

“…[ 17 ] 46 Abdominal distension Carboplatin + Paclitaxcel 914 Died after 4 months postoperatively Aslam et al . [ 13 ] 76 Abdominal pain None Within the normal range Died postoperatively Chenevert et al . [ 16 ] 53 Abdominal mass Carboplatin + Paclitaxcel 80 Died after 3 months postoperatively 53 Abdominal distension Cisplatin + Etoposide 5.7 Died after 7 months postoperatively Behnam et al .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature

Park

Lee

et al. 2014

World J Surg Onc

View full text Add to dashboard Cite

Large cell neuroendocrine carcinoma (LCNC) of the ovary, or ovarian undifferentiated non-small cell carcinoma of neuroendocrine type, is a rare entity that is frequently associated with ovarian surface epithelial tumors. Few cases have been reported in the literature. LCNC is an aggressive tumor with tendency to present at advanced stages and to cause death after a short postoperative duration. We report three cases of LCNC diagnosed histopathologically. Immunohistochemically, the tumor cells were positive for chromogranin A, NSE, CD56, and pancytokeratin. The patients were treated postoperatively with combination chemotherapy. Due to the rarity of LCNC, the general consensus on standard therapy is not established. Although most patients are at stage I, the biological aggressiveness and poor prognosis of the tumors have been reported in previous reports despite extensive surgery and chemotherapy.

show abstract